AGP Executive Report
Last update: 8 hours agoVaccine Trial Halted: Guinea-Bissau has refused approval for a US-backed hepatitis B study involving 14,000 newborns, and a researcher confirmed it will not proceed. The plan would have delayed vaccination for half the babies until six weeks of age, prompting strong ethical objections. Judicial police searched the Bandim Health Project’s offices and seized vaccine doses as part of an investigation; officials said the seizure alone does not indicate a problem with vaccine quality or safety. Seismic Data: PetroGuin and TGS have agreed to reprocess more than 11,000 square kilometres of 3D seismic data off Guinea-Bissau, using updated imaging methods to improve views of potential oil and gas targets. Work is expected to begin in late 2026, with results due in 2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![YouTube video thumbnail: Illegal Gold Mining: Who Profits From Africa’s Gold Smuggling? [Business Africa]](https://i3.ytimg.com/vi/OA881tNCUVE/mqdefault.jpg)
